Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation
Glycolysis is a central metabolic pathway that converts glucose into pyruvate. Although pyruvate has been well documented to be a key and terminal metabolite of glycolysis with both energetic and biosynthetic roles, its non-metabolic functions remain unexplored.
Here, we report a pyruvate-mediated protein post-translational modification (PTM), protein pyruvylation. We reveal that high glucose-upregulated glycolysis promotes signal transducer and activator of transcription 1 (STAT1) pyruvylation at Lys201 (K201), which blocks STAT1 and signal transducer and activator of transcription 2 (STAT2) interaction, thus suppressing type I interferon (IFN-I) signaling and antiviral immune activity.
Consequently, STAT1-K201R knockin mice exhibit enhanced IFN-I antiviral immunity. Importantly, high glucose promotes STAT1 pyruvylation and attenuates immune response to either virus infection or IFN-I treatment in humans.
This study identifies the protein pyruvylation modification, reveals a non-metabolic function of the metabolite pyruvate, and provides insights into how high glucose impairs IFN-I antiviral immunity through pyruvate, offering strategies to improve IFN-I immune activity for both preventing and treating viral infections.
HIGHLIGHTS
• Pyruvate is a natural suppressor of IFN-I immune activity
• PKM2 and pyruvate promote STAT1 pyruvylation at Lys201
• STAT1 pyruvylation inhibits STAT1-STAT2 binding and IFN-I signaling
• Inhibition of STAT1 pyruvylation enhances in vivo antiviral immunity
Web | DOI | PDF | Cell | Open Access
Yibo Zuo; Qin Wang; Wanying Tian; Xinhe Wang; Zhijin Zheng; Wei He; Renxia Zhang; Qian Zhao; Ying Miao; Yukang Yuan; Tingting Zhang; Qun Cui; Yuerong Zhang; Chunyan Liu; Haiyan Zhou; Hui Zheng
Glycolysis is a central metabolic pathway that converts glucose into pyruvate. Although pyruvate has been well documented to be a key and terminal metabolite of glycolysis with both energetic and biosynthetic roles, its non-metabolic functions remain unexplored.
Here, we report a pyruvate-mediated protein post-translational modification (PTM), protein pyruvylation. We reveal that high glucose-upregulated glycolysis promotes signal transducer and activator of transcription 1 (STAT1) pyruvylation at Lys201 (K201), which blocks STAT1 and signal transducer and activator of transcription 2 (STAT2) interaction, thus suppressing type I interferon (IFN-I) signaling and antiviral immune activity.
Consequently, STAT1-K201R knockin mice exhibit enhanced IFN-I antiviral immunity. Importantly, high glucose promotes STAT1 pyruvylation and attenuates immune response to either virus infection or IFN-I treatment in humans.
This study identifies the protein pyruvylation modification, reveals a non-metabolic function of the metabolite pyruvate, and provides insights into how high glucose impairs IFN-I antiviral immunity through pyruvate, offering strategies to improve IFN-I immune activity for both preventing and treating viral infections.
HIGHLIGHTS
• Pyruvate is a natural suppressor of IFN-I immune activity
• PKM2 and pyruvate promote STAT1 pyruvylation at Lys201
• STAT1 pyruvylation inhibits STAT1-STAT2 binding and IFN-I signaling
• Inhibition of STAT1 pyruvylation enhances in vivo antiviral immunity
Web | DOI | PDF | Cell | Open Access